Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC)

Documents similaires

• Co-delivery of Gefitinib and Paclitaxel as Inhalable Nano Carriers for Non Small Cell Lung Cancer
  par: Walvekar Shreya
• Cisplatin- Loaded Oxidized Graphene Nanoribbons for Non-Small Cell Lung Carcinoma (NSCLC)
  par: Steffi Augustine
• Targeted Delivery of Nisin and Nisin-Chitosan Complex Using Dendrimers in Lung Cancer
  par: Mayekar Srushti
• Drug Latentiation of a Gefitinib, An Epidermal Growth Factor Receptor (EGFR) Inhibitor, Anticancer (Pro-Drug of Gefitinib) with Cell Line Studies
  par: Mrunal Sharma
  Publié: (2017)
• Hyaluronic acid modified Erlotinib-Chitosan nanoparticles for Non-small cell lung cancer
  par: Chaitali Taiwade